186 related articles for article (PubMed ID: 30111586)
21. Hypertrophic cardiomyopathy, sudden death, and implantable cardiac defibrillators: how low the bar?
Nishimura RA; Ommen SR
JAMA; 2007 Jul; 298(4):452-4. PubMed ID: 17652299
[No Abstract] [Full Text] [Related]
22. [Implantable defibrillators. Role of the defibrillator in treatment and prevention of sudden death].
Lellouche D; Pujadas-Berthault P; Elbaz N
Presse Med; 2001 May 5-12; 30(17):871-3. PubMed ID: 11402945
[TBL] [Abstract][Full Text] [Related]
23. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
Proclemer A; Ghidina M
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
[No Abstract] [Full Text] [Related]
24. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
[TBL] [Abstract][Full Text] [Related]
25. The role of prophylactic implantable cardioverter defibrillators to prevent sudden cardiac death.
Talajic M; Mitchell LB; Hadjis T
Can J Cardiol; 2000 Jun; 16 Suppl C():26C-8C. PubMed ID: 10887275
[No Abstract] [Full Text] [Related]
26. Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD).
Vehmeijer JT; Koyak Z; Leerink JM; Zwinderman AH; Harris L; Peinado R; Oechslin EN; Robbers-Visser D; Groenink M; Boekholdt SM; de Winter RJ; Oliver JM; Bouma BJ; Budts W; Van Gelder IC; Mulder BJM; de Groot JR
Heart Rhythm; 2021 May; 18(5):785-792. PubMed ID: 33465514
[TBL] [Abstract][Full Text] [Related]
27. Implantable cardioverter-defibrillator and mortality in dialysis patients.
Saravanan P; Davidson NC
Am J Cardiol; 2009 Jun; 103(11):1623-4. PubMed ID: 19463528
[No Abstract] [Full Text] [Related]
28. Sudden cardiac death.
Kuriachan VP; Sumner GL; Mitchell LB
Curr Probl Cardiol; 2015 Apr; 40(4):133-200. PubMed ID: 25813838
[TBL] [Abstract][Full Text] [Related]
29. Ventricular arrhythmias: from risk assessment for sudden cardiac death to therapeutic intervention.
Wissner E; Kuck KH
Herz; 2009 Nov; 34(7):503-4. PubMed ID: 20091249
[No Abstract] [Full Text] [Related]
30. Epidemiology of ventricular tachyarrhythmia : Any changes in the past decades?
Jong-Ming Pang B; Green MS
Herzschrittmacherther Elektrophysiol; 2017 Jun; 28(2):143-148. PubMed ID: 28484840
[TBL] [Abstract][Full Text] [Related]
31. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials.
Ezekowitz JA; Armstrong PW; McAlister FA
Ann Intern Med; 2003 Mar; 138(6):445-52. PubMed ID: 12639076
[TBL] [Abstract][Full Text] [Related]
32. Utilization of implantable cardioverter-defibrillators for the prevention of sudden cardiac death in emerging countries: Improve SCA clinical trial.
Zhang S; Ching CK; Huang D; Liu YB; Rodriguez-Guerrero DA; Hussin A; Kim YH; Chasnoits AR; Cerkvenik J; Lexcen DR; Muckala K; Brown ML; Cheng A; Singh B;
Heart Rhythm; 2020 Mar; 17(3):468-475. PubMed ID: 31561030
[TBL] [Abstract][Full Text] [Related]
33. Sudden cardiac death and implantable cardioverter-defibrillators.
Turakhia MP
Am Fam Physician; 2010 Dec; 82(11):1357-66. PubMed ID: 21121520
[TBL] [Abstract][Full Text] [Related]
34. Survivors of acute myocardial infarction: who is at risk for sudden cardiac death?
Shen WK; Hammill SC
Mayo Clin Proc; 1991 Sep; 66(9):950-62. PubMed ID: 1921506
[TBL] [Abstract][Full Text] [Related]
35. [Implantable defibrillators--current status of guidelines. Recognized and possible indications--prerequisites].
Andresen D
Fortschr Med; 1996 Apr; 114(11):128-32. PubMed ID: 8682425
[TBL] [Abstract][Full Text] [Related]
36. The implantable cardioverter-defibrillator minimalist: an approach to patient follow-up and management of implantable defibrillators.
Sweeney MO
Circulation; 2012 Jul; 126(3):369-77. PubMed ID: 22801654
[No Abstract] [Full Text] [Related]
37. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
Priori SG; Blomström-Lundqvist C; Mazzanti A; Blom N; Borggrefe M; Camm J; Elliott PM; Fitzsimons D; Hatala R; Hindricks G; Kirchhof P; Kjeldsen K; Kuck KH; Hernandez-Madrid A; Nikolaou N; Norekvål TM; Spaulding C; Van Veldhuisen DJ;
Europace; 2015 Nov; 17(11):1601-87. PubMed ID: 26318695
[No Abstract] [Full Text] [Related]
38. Ventricular arrhythmias and sudden cardiac death: an insight from recent multicenter randomized clinical trials.
Akiyama T
Keio J Med; 1996 Dec; 45(4):313-7. PubMed ID: 9023449
[TBL] [Abstract][Full Text] [Related]
39. Sudden cardiac death in heart failure with preserved ejection fraction: a target for therapy?
Vaduganathan M; Patel RB; Shah SJ; Butler J
Heart Fail Rev; 2016 Jul; 21(4):455-62. PubMed ID: 26762335
[TBL] [Abstract][Full Text] [Related]
40. Clinical management and prevention of sudden cardiac death.
Yousuf O; Chrispin J; Tomaselli GF; Berger RD
Circ Res; 2015 Jun; 116(12):2020-40. PubMed ID: 26044254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
